Kidney Cancer Progression Linked to Preop Cardiovascular Biomarkers

Share this content:
Elevated serum levels of BNP and NT-proBNP prior to nephrectomy are associated with an increased likelihood of RCC progression.
Elevated serum levels of BNP and NT-proBNP prior to nephrectomy are associated with an increased likelihood of RCC progression.

Elevated preoperative serum levels of 2 cardiovascular biomarkers are associated with an increased likelihood of progression of renal cell carcinoma (RCC), according to a new study.

In advanced RCC, elevated serum levels of these biomarkers—brain natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP)—are associated with worse Karnofsky performance status, undifferentiated tumor histology, local invasion, and a larger tumor mass, investigators reported in Open Heart (2018;5:e000666).

The mean preoperative BNP and NT-proBNP levels were 40.3 and 198.2 pg/mL, respectively, among patients with a Karnofsky performance status (KPS) greater than 80% and 56.3 and 321.2 pg/mL, respectively, for those with a KPS less than 80%. The mean preoperative BNP and NT-proBNP levels increased along with tumor grade, rising from 23.4 and 129.0 pg/mL, respectively, among patients with grade 1 tumors to 63.1 and 382.1 pg/mL, respectively, for those with grade 4 tumors. Patients with pT 1/2 tumors had mean preoperative BNP and NT-proBNP levels of 28.9 and 113.7 pg/mL, respectively, whereas those with pT 3/4 tumors had levels of 55.7 and 315 pg/mL, respectively. Mean preoperative BNP and NT-proBNP levels were significantly higher among patients with versus without distant metastasis: 34.7 and 174.4 pg/mL, respectively, compared with 60.1 and 327.4 pg/mL.

The investigators concluded that their findings suggest that BNP and NT-proBNP are indicators of subclinical functional and structural myocardial damage in patients with advanced RCC.

The study, by Takao Kamai, MD, and collaborators at Dokkyo Medical University Mibu Tochigi, Japan, included 129 patients with clear cell RCC who underwent nephrectomy. The median preoperative serum level of BNP and NT-proBNP were 34.9 and 178.8 pg/mL. The researchers used these medians to divide patients into 2 groups: those above and below the medians. BNP and NT-proBNP levels above the median each was associated with shorter survival compared with levels below the median.

Following surgery, mean serum levels of BNP and NT-proBNP decreased significantly: BNP from 44.2 to 23.7 pg/mL and NT-BNP from 227.5 to 141.1 pg/mL. Dr Kamai's group hypothesized that RCC might produce BNP and NT-proBNP because serum levels of these hormones fell after surgery. They noted, however, that BNP expression was actually very low in both RCC and normal kidney tissues compared with positive control tissues (normal adrenal gland and liver). This indicates that the hormones were not mainly or directly produced by either the tumors or normal kidney tissues, “suggesting secretion from other organs such as the heart by a mechanism through which RC has some effect on the myocardium,” they wrote.

BNP and NT-proBNP normally are secreted by atrial and/or ventricular myocardial cells in response to volume or pressure overload, and production is related to the severity of myocardial dysfunction, the authors explained.

Reference

Kamai T, Tokura Y, Uematsu T, et al. Elevate serum levels of cardiovascular biomarkers are associated with progression of renal cancer. Open Heart. 2018;5:e000666. 

You must be a registered member of Renal and Urology News to post a comment.